Larry Bucshon actually said...
I am concerned about the drug pricing protocols in the Build Back Better Act, and they would have the opposite effect limiting research and hampering innovation, in my view.
Context
Bucshon criticizes the drug pricing measures in the Build Back Better Act for hindering innovation.
12/07/2021